|
APVO Aptevo Therapeutics Inc 1671584 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-6,697,000.00 |
| Balance Sheet |
|
Current Assets
|
$15,984,000.00 |
|
Assets
|
$19,902,000.00 |
|
Current Liabilities
|
$4,760,000.00 |
|
Liabilities
|
$8,290,000.00 |
|
Equity
|
$11,612,000.00 |
|
Shares Out
|
1203753.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,965,000.00 |
| Market Analysis |
Market Cap
|
$4,971,499.89 |
|
Price
|
$4.00 |
|
BVPS
|
9.65 |
|
PB
|
0.43 |
|
EPS
|
-6.41 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APVO documents filed with the SEC.
APVO Filings
Clear
